Showing results (1091-1100 of 1,547) with videos related to

Sort By:
Pageof 155
Neuro-Oncology|October 10, 2024
Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection-Update 1Martin J van den Bent, Enrico Franceschi, Mehdi Touat, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|April 10, 2020
[The development and validation of risk prediction model for lung cancer: a systematic review]Z Y Lyu, F W Tan, C Q Lin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1996
Intratumoral administration of 5-[123I]iodo-2'-deoxyuridine in a patient with a brain tumorA I Kassis, S S Tumeh, P Y Wen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2013
Phase I study of GRN1005 in recurrent malignant gliomaJan Drappatz, Andrew Brenner, Eric T Wong, et al.
Neuro-Oncology|February 5, 2019
A low percentage of metastases in deep brain and temporal lobe structuresTed K Yanagihara, J Ricardo McFaline-Figueroa, Nicholas J Giacalone, et al.
Neuro-Oncology|March 28, 2020
Evaluation of RAPNO criteria in medulloblastoma and other leptomeningeal seeding tumors using MRI and clinical dataJian Peng, Hao Zhou, Oliver Tang, et al.
Oncotarget|May 14, 2016
MAPK activation and HRAS mutation identified in pituitary spindle cell oncocytomaMichael B Miller, Wenya Linda Bi, Lori A Ramkissoon, et al.
Neuro-Oncology|October 15, 2014
Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD)Patrick Y Wen, Timothy F Cloughesy, Benjamin M Ellingson, et al.
Neuro-Oncology|January 8, 2023
Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survivalBenjamin M Ellingson, Patrick Y Wen, Susan M Chang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 2, 2021
The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid featuresChristopher J Schwartz, Edi Brogi, Antonio Marra, et al.
Pageof 155